Publication | Closed Access

LFG-500, a novel synthetic flavonoid, suppresses epithelial–mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment

InflammationInflammatory MicroenvironmentNovel Synthetic FlavonoidAnti-inflammatoryInflammatory Lung DiseaseChemoprevention StrategyLung InflammationMedicineEpithelial–mesenchymal TransitionImmunologyPulmonary PharmacologyCancer BiologyLung CancerPharmacologyCell BiologyTumor MicroenvironmentTumor Biology